ruxolitinib
novartis,incyte
['rux,(-crux),(-trux),(-deruxtecan)', 'incyte']
dr. bhatt: ruxo for steroid refractory sclerotic cgvhd, multi-center study, 72% got ruxo for over 6mo, pr rate 45% in skin/joint, improved pro. effective therapy! our pts participated in this study!! #ash22 
Hem/Onc, BMT, CAR-T, Immunology, Math, Machine Learning, Python, R, SAS. Tweets are my personal views